MedPath

Taurine Supplementation and Training Effects on Energy Metabolism, Inflammation and Oxidative Stress in Obese Women

Not Applicable
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Taurine
Other: Exercise training
Registration Number
NCT04279600
Lead Sponsor
University of Sao Paulo
Brief Summary

Taurine supplementation researches have increased due to its antioxidant and anti-inflammatory actions, and its ability to modulate lipid metabolism by stimulating the expression of proteins that regulates mitochondrial biogenesis and increases respiratory function (PGC-1α and PPAR) and irisin release when associated to exercise. Since obesity can induce metabolic disorders including abnormal production of adipokines and activation of pro-inflammatory signaling pathways also mitochondrial metabolism dysfunction in the adipose tissue, the use of taurine would be a new strategy for obesity prevention and treatment. Moreover, the association of taurine and exercise could improve exercise effects, promote higher energy expenditure and increase mitochondrial respiration, consequently resulting in weight loss. Therefore, the present investigation aims to evaluate the effects of the association of taurine supplementation and a combined exercise training protocol (aerobic and strength) on resting energy expenditure, weight, body composition, blood markers of inflammation and oxidative stress, telomeres length, and mitochondrial function and the expression of genes that regulates energy metabolism and lipid oxidation in the white adipose tissue in obese women.

Detailed Description

A double-blind placebo-controlled study was conducted with 24 obese women (32.9±6.3 years). Capsules of taurine (3 grams) (GTau) or placebo (GP) were daily supplemented 2 hours before training. The training program was composed of aerobic and strength exercises during one hour, 3 times a week, for an 8-week period (intensity of 80% heart rate). The taurine supplemented group received only taurine capsules (3g/day) during 8 weeks. Measurement of weight, hip and waist circumference, and body composition (by Deuterium oxide) were performed before and after the intervention. Resting energy expenditure and nutrients oxidation were assessed by calorimetry.

In order to check the effects of the intervention, abdominal tissue biopsy will be performed for white adipose tissue analysis, evaluation of mitochondrial function and quantification of the expression of genes related to energy metabolism and lipid oxidation and taurine pathway; blood collection will be done for quantification of taurine levels, inflammatory (IL-10, IL-15, IL-6, IL-1, TNF-α, and CRP), adipokines (adiponectin, adipsin, resistin, fetuin and leptin) and oxidative stress (GPx, SOD and MDA) markers. Also, evaluation of telomere length was performed. Body composition was evaluated by deuterium oxide method, weight, waist and hip circumference were accessed. All the measurements were performed before and after the intervention period.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Body Mass Index of 30 to 40 kg / m²
  • Sedentary
  • No associated co morbidity
Exclusion Criteria
  • Women who have a medical impediment to the practice of physical exercise
  • Women that have undergone bariatric surgery
  • Menopause, cancer or any metabolic disease
  • Smokers
  • Alcoholics
  • Insulin-dependent diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Taurine supplementation associated to exercise trainingExercise trainingTaurine supplementation composed of capsules of taurine powder. Dosage: 3 grams/day Frequency: 1 time/day Duration: 8 weeks Exercise training Exercise Protocol: a combination of strength and aerobic exercises Duration: 2 weeks of adaptation and 8 weeks of physical training. Frequency: 3 times/week Duration: 55 minutes/session Intensity: 75 to 90% of maximum heart rate
Placebo supplementation associated to exercise trainingExercise trainingPlacebo supplementation composed of capsules of starch powder. Dosage: 3 grams/day Frequency: 1 time/day Duration: 8 weeks Exercise training Exercise Protocol: a combination of strength and aerobic exercises Duration: 2 weeks of adaptation and 8 weeks of physical training. Frequency: 3 times/week Duration: 55 minutes/session Intensity: 75 to 90% of maximum heart rate
Placebo supplementation associated to exercise trainingPlaceboPlacebo supplementation composed of capsules of starch powder. Dosage: 3 grams/day Frequency: 1 time/day Duration: 8 weeks Exercise training Exercise Protocol: a combination of strength and aerobic exercises Duration: 2 weeks of adaptation and 8 weeks of physical training. Frequency: 3 times/week Duration: 55 minutes/session Intensity: 75 to 90% of maximum heart rate
Taurine supplementationTaurineTaurine supplementation composed of capsules of taurine powder. Dosage: 3 grams/day Frequency: 1 time/day Duration: 8 weeks
Taurine supplementation associated to exercise trainingTaurineTaurine supplementation composed of capsules of taurine powder. Dosage: 3 grams/day Frequency: 1 time/day Duration: 8 weeks Exercise training Exercise Protocol: a combination of strength and aerobic exercises Duration: 2 weeks of adaptation and 8 weeks of physical training. Frequency: 3 times/week Duration: 55 minutes/session Intensity: 75 to 90% of maximum heart rate
Primary Outcome Measures
NameTimeMethod
Change from baseline in white adipose tissue mitochondrial respiration at 8 weekseight weeks

A subcutaneous adipose tissue sample collected for analysis of mitochondrial respiration (mitochondrial uncoupled state, phosphorylation state and electron transport system maximal capacity) were calculated at 8 weeks in comparison to the baseline.

Changes from baseline in macronutrient intake at 8 weekseight weeks

Change of macronutrient intake were calculated at 8 weeks in comparision to the baseline.

Changes from baseline in body composition at 8 weekseight weeks

Change of body composition through deuterium oxide method were calculated at 8 weeks in comparision to the baseline.

Changes from baseline in interleukines levels at 8 weekseight weeks

Change of inflammatory markers such as interleukines 6, 10 and 15 were calculated at 8 weeks in comparision to the baseline.

Changes from baseline in superoxide dismutase levels at 8 weekseight weeks

Change of oxidative stress markers such as superoxide dismutase were calculated at 8 weeks in comparision to the baseline.

Changes from baseline in total calorie intake at 8 weekseight weeks

Change of total calorie intake were calculated at 8 weeks in comparision to the baseline.

Change from baseline in indirect calorimetry at 8 weekseight weeks

Change of energy expenditure and lipids oxidation were calculated at 8 weeks in comparision to the baseline.

Changes from baseline in cytokine levels at 8 weekseight weeks

Change of inflammatory markers such as adiponectin, resistin and adipsin were calculated at 8 weeks in comparision to the baseline.

Changes from baseline in glutathione peroxidase levels at 8 weekseight weeks

Change of oxidative stress markers such as glutathione peroxidase were calculated at 8 weeks in comparision to the baseline.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

School of Physical Education and Sport of Ribeirão Preto

🇧🇷

Ribeirão Preto, Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath